This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farah, C. A.
Right arrow Articles by Sossin, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farah, C. A.
Right arrow Articles by Sossin, W. S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2008, p. 4719-4733, Vol. 28, No. 15
0270-7306/08/$08.00+0     doi:10.1128/MCB.00178-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Physiological Role for Phosphatidic Acid in the Translocation of the Novel Protein Kinase C Apl II in Aplysia Neurons{triangledown}

Carole A. Farah, Ikue Nagakura, Daniel Weatherill, Xiaotang Fan, and Wayne S. Sossin*

Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada

Received 4 February 2008/ Returned for modification 4 March 2008/ Accepted 17 May 2008

In Aplysia californica, the serotonin-mediated translocation of protein kinase C (PKC) Apl II to neuronal membranes is important for synaptic plasticity. The orthologue of PKC Apl II, PKC{varepsilon}, has been reported to require phosphatidic acid (PA) in conjunction with diacylglycerol (DAG) for translocation. We find that PKC Apl II can be synergistically translocated to membranes by the combination of DAG and PA. We identify a mutation in the C1b domain (arginine 273 to histidine; PKC Apl II-R273H) that removes the effects of exogenous PA. In Aplysia neurons, the inhibition of endogenous PA production by 1-butanol inhibited the physiological translocation of PKC Apl II by serotonin in the cell body and at the synapse but not the translocation of PKC Apl II-R273H. The translocation of PKC Apl II-R273H in the absence of PA was explained by two additional effects of this mutation: (i) the mutation removed C2 domain-mediated inhibition, and (ii) the mutation decreased the concentration of DAG required for PKC Apl II translocation. We present a model in which, under physiological conditions, PA is important to activate the novel PKC Apl II both by synergizing with DAG and removing C2 domain-mediated inhibition.


* Corresponding author. Mailing address: Department of Neurology and Neurosurgery, McGill University, Montreal Neurological Institute, BT 110, 3801 University Street, Montreal, Quebec H3A 2B4, Canada. Phone: (514) 398-1486. Fax: (514) 398-8106. E-Mail: wayne.sossin{at}mcgill.ca

{triangledown} Published ahead of print on 27 May 2008.


Molecular and Cellular Biology, August 2008, p. 4719-4733, Vol. 28, No. 15
0270-7306/08/$08.00+0     doi:10.1128/MCB.00178-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Farah, C. A., Weatherill, D., Dunn, T. W., Sossin, W. S. (2009). PKC Differentially Translocates during Spaced and Massed Training in Aplysia. J. Neurosci. 29: 10281-10286 [Abstract] [Full Text]